SPONSORS:
| ZURICH, SWITZERLAND |
PLATINUM SPONSOR
Deallus is a Competitive Strategy Consultancy that supports strategy development and decision making in life science organisations around the world.
We help clients win by providing objective guidance that allows them to develop and maintain a competitive strategy for their product or franchise or
corporation.
Deallus is a Competitive Strategy Consultancy that supports strategy development and decision making in life science organisations around the world.
We help clients win by providing objective guidance that allows them to develop and maintain a competitive strategy for their product or franchise or
corporation.
GOLD SPONSOR
Lifescience Dynamics Limited is a specialist in primary human intelligence providing new intelligence – i.e. not known to our clients previously. Clients
hire us to collect ‘high value intelligence’ which may impact on their strategic decisions. Our clients expect to receive “hard intelligence” which is not in
the public domain, which is not written or published anywhere and certainly not available through any commercial databases.
Lifescience Dynamics Limited is a specialist in primary human intelligence providing new intelligence – i.e. not known to our clients previously. Clients
hire us to collect ‘high value intelligence’ which may impact on their strategic decisions. Our clients expect to receive “hard intelligence” which is not in
the public domain, which is not written or published anywhere and certainly not available through any commercial databases.
Evalueserve is a global specialist for knowledge processes with a global team of over 2,200 professionals. As a trusted partner, Evalueserve analyzes,
improves and executes knowledge-intensive processes and leverages its proprietary technology to enhance efficiency and effectiveness. Evalueserve
has dedicated on-site teams and scalable global knowledge centers in Chile, China, India and Romania, which provide multi-time zone and multi-
lingual services.
Evalueserve’s knowledge solutions include customized research and analytics services for leading-edge companies worldwide. By working with
Evalueserve, clients benefit from higher productivity, improved quality, freed-up management time, better access to knowledge and information across
all parts of the company, and adding new capabilities to their organization.
improves and executes knowledge-intensive processes and leverages its proprietary technology to enhance efficiency and effectiveness. Evalueserve
has dedicated on-site teams and scalable global knowledge centers in Chile, China, India and Romania, which provide multi-time zone and multi-
lingual services.
Evalueserve’s knowledge solutions include customized research and analytics services for leading-edge companies worldwide. By working with
Evalueserve, clients benefit from higher productivity, improved quality, freed-up management time, better access to knowledge and information across
all parts of the company, and adding new capabilities to their organization.
Since 1988, Fletcher/CSI Healthcare Strategies, a leading global life-science consulting and research company, has provided in-depth performance
consulting, advanced training and customized market and competitor intelligence research to the pharmaceutical, medical device and biotech
industries. Fletcher/CSI customized consulting services allows Senior, Brand, Business Development and Strategic Planning managers to make
better decisions aimed at maximizing portfolio revenues, identifying market opportunities that lead to further revenue growth.
Fletcher/CSI’s experienced pharmaceutical brand consulting, research and medical specialists team combines both life science business acumen
with therapeutic expertise to deliver in-depth insight and analysis into current and future market and competitor events and trends.
Fletcher/CSI Healthcare Strategies is a division of Fletcher/CSI, headquartered in Williston, Vermont with offices in Philadelphia, Atlanta, and Charlotte.
Our global network consists of offices in every major pharmaceutical market and clinical trial initiative around the world. For more information please
visit our web site: www.fletchercsi-healthcare.com or call (802) 660-9636 or (610) 361-1209 for further information.
consulting, advanced training and customized market and competitor intelligence research to the pharmaceutical, medical device and biotech
industries. Fletcher/CSI customized consulting services allows Senior, Brand, Business Development and Strategic Planning managers to make
better decisions aimed at maximizing portfolio revenues, identifying market opportunities that lead to further revenue growth.
Fletcher/CSI’s experienced pharmaceutical brand consulting, research and medical specialists team combines both life science business acumen
with therapeutic expertise to deliver in-depth insight and analysis into current and future market and competitor events and trends.
Fletcher/CSI Healthcare Strategies is a division of Fletcher/CSI, headquartered in Williston, Vermont with offices in Philadelphia, Atlanta, and Charlotte.
Our global network consists of offices in every major pharmaceutical market and clinical trial initiative around the world. For more information please
visit our web site: www.fletchercsi-healthcare.com or call (802) 660-9636 or (610) 361-1209 for further information.
Fuld & Co, the global leader in competitive intelligence, delivers customized research and analysis on markets, competitors, suppliers, and customers.
Our findings and recommendations enable clients to make informed judgments related to new product introductions, life-cycle management initiatives,
restructuring, organizational bench marking and a variety of other critical business decisions. www.fuld.com
Our findings and recommendations enable clients to make informed judgments related to new product introductions, life-cycle management initiatives,
restructuring, organizational bench marking and a variety of other critical business decisions. www.fuld.com
Since 1992, best practice leaders in primary CI for the pharma/biotech/med. device sectors across 12 therapeutic areas in 32 countries with offices in
Switzerland, California, New Jersey, China, India and Brazil.:
Switzerland, California, New Jersey, China, India and Brazil.:
- Systematic CI tracking programs
- Medical conference coverage
- Early stage/pre-clinical through commercialization & post-launch monitoring
- Strategic market opportunity/threat assessments
- Due diligence investigations to support M&A, licensing & partnering decisions
- Strategic competitor benchmarking [e.g., phase IV practices, biomarkers, sales models, health outcomes, etc.)
- Counter-intelligence assessments & training
- All I.S.I.S. investigators have medical and/or intelligence backgrounds
- Discrete, actionable, resourceful & innovative while adhering to impeccable ethical standards
- Generic and biosimilar threat assessments
Sedulo Group is a leading competitive and market intelligence firm. It’s committed to leveraging its unique primary source intelligence collection
capabilities to provide the most accurate and comprehensive intelligence available today. The firm provides its clients with the intelligence they need to
out maneuver and outperform the market and the competition.
capabilities to provide the most accurate and comprehensive intelligence available today. The firm provides its clients with the intelligence they need to
out maneuver and outperform the market and the competition.
Value Edge is an international business research and analytics firm that delivers high value customized business solutions with insightful analysis to
clients across the pharmaceutical and biotech industry. We offer in-depth services in secondary CI for products and companies. Our activities include
competitor profiling, competitive landscapes, competitor knowledge bases, clinical trial analytics and social media mining & analytics.
clients across the pharmaceutical and biotech industry. We offer in-depth services in secondary CI for products and companies. Our activities include
competitor profiling, competitive landscapes, competitor knowledge bases, clinical trial analytics and social media mining & analytics.
Join Our Mailing List |
Contact Us Privacy Policy Terms of Use © Copyright Pharma CI Conference & Exhibition. All Rights Reserved.
Packages
Our exhibitor and sponsorship opportunities are specifically designed to maximize your business development, lead generation, and networking objectives.
Be sure to book early!
Breakfast is in the exhibit hall, and other break times are scheduled for 1 hour in length, once in the morning and once in the afternoon to ensure high-quality
networking. Refreshment and coffee will be served in the exhibit hall. Exhibit booths are 8x10 with 2 full access passes to the conference sessions and all
socializing functions.
Contact the conference organizer at ayueh@pharmaciconference.com or at +1.212.228.7974 for more information.
Our exhibitor and sponsorship opportunities are specifically designed to maximize your business development, lead generation, and networking objectives.
Be sure to book early!
Breakfast is in the exhibit hall, and other break times are scheduled for 1 hour in length, once in the morning and once in the afternoon to ensure high-quality
networking. Refreshment and coffee will be served in the exhibit hall. Exhibit booths are 8x10 with 2 full access passes to the conference sessions and all
socializing functions.
Contact the conference organizer at ayueh@pharmaciconference.com or at +1.212.228.7974 for more information.
The Financial Times, one of the world’s leading business news organisations, provides an essential source of news, comment, data and analysis for
the global business community. Our corporate service extracts the intelligence that's relevant to your business and delivers it using the technologies
that suit you best. Millions of people now access our journalism via FT.com, mobile, tablet, and third party platforms such as Bloomberg, Factiva and
LexisNexis. For more information, visit www.ft.com/corporate
the global business community. Our corporate service extracts the intelligence that's relevant to your business and delivers it using the technologies
that suit you best. Millions of people now access our journalism via FT.com, mobile, tablet, and third party platforms such as Bloomberg, Factiva and
LexisNexis. For more information, visit www.ft.com/corporate
BioMedTracker is an independent research service that offers proprietary clinical assessments and patient-based revenue forecasts of developmental
drugs within a comprehensive and intuitive drug information database. Clients from the pharmaceutical, biotech, and investment industries rely on
BioMedTracker for its insight on the likelihood of approval, commercial potential, and future data and regulatory catalysts for drugs within the
competitive landscape of every important disease and indication. Over the last several years, BioMedTracker has become the leader in providing
objective information alongside subjective clinical assessments on pipeline drugs worldwide. Visit www.biomedtracker.com for more information.
drugs within a comprehensive and intuitive drug information database. Clients from the pharmaceutical, biotech, and investment industries rely on
BioMedTracker for its insight on the likelihood of approval, commercial potential, and future data and regulatory catalysts for drugs within the
competitive landscape of every important disease and indication. Over the last several years, BioMedTracker has become the leader in providing
objective information alongside subjective clinical assessments on pipeline drugs worldwide. Visit www.biomedtracker.com for more information.
SILVER SPONSOR
Citeline provides the world’s most comprehensive real-time drug development intelligence covering global clinical trials, investigators, investigator
assessment, and now historical trial timelines and timeline predictions. Our services combine both data and on-demand access to our analysts, to
give you up-to-the-minute information for your critical competitive decisions.
Citeline provides the world’s most comprehensive real-time drug development intelligence covering global clinical trials, investigators, investigator
assessment, and now historical trial timelines and timeline predictions. Our services combine both data and on-demand access to our analysts, to
give you up-to-the-minute information for your critical competitive decisions.
 |  |  |  |  |  |  |  |  |  |  |
SILVER SPONSOR
Pennside Partners Ltd. is a global business consulting company serving the pharmaceutical, biotech and medical device sectors. We provide
business development support services, including clinical pipeline reviews; sales and marketing benchmarking; and market access and
reimbursement studies. A common theme is detailed primary source research and analysis conducted by experienced consultants.
Pennside Partners Ltd. is a global business consulting company serving the pharmaceutical, biotech and medical device sectors. We provide
business development support services, including clinical pipeline reviews; sales and marketing benchmarking; and market access and
reimbursement studies. A common theme is detailed primary source research and analysis conducted by experienced consultants.
The Larvol Group, LLC provides innovative intelligence solutions to the pharmaceutical industry. Our reports offer customized weekly dashboards,
news tracking, and other analytics within a given field. With over 120 professionals worldwide, we have expertise in all therapeutic areas including
oncology, pain management, inflammation, CNS, cardiovascular disease and diabetes. Our clients include 9 of the top 10 pharmaceutical companies.
For more information or to receive a free sample report, please visit our website at www.larvol.com.
news tracking, and other analytics within a given field. With over 120 professionals worldwide, we have expertise in all therapeutic areas including
oncology, pain management, inflammation, CNS, cardiovascular disease and diabetes. Our clients include 9 of the top 10 pharmaceutical companies.
For more information or to receive a free sample report, please visit our website at www.larvol.com.
Prescient Life Sciences (formerly CIS Life Sciences) is a global consultancy (since 1995), with offices in London, New Jersey, San Francisco,
New Delhi and Beijing. We partner with biopharmaceutical clients and other organizations supporting the life sciences industry in the provision of
evidence based solutions. The value added nature of our client engagements help optimize their product and corporate development strategies,
maximizing return on investment opportunities. Our solutions are based on targeted and timely evidence combined with industry, functional and
disease area expertise culminating in actionable implications and recommendations.
The practices are split by the following business function:
and support the major therapeutic areas including: Oncology & Hematology; Immunology, Autoimmunity & Inflammation; Cardiology; Metabolic
Diseases; Neurology & Psychiatry; Infectious Diseases & Vaccines; Ophthalmology; Dermatology; Bone Disease; Gastroenterology & Urology;
and Women’s Health.
For further information please contact us on enquiries@prescientls.com
New Delhi and Beijing. We partner with biopharmaceutical clients and other organizations supporting the life sciences industry in the provision of
evidence based solutions. The value added nature of our client engagements help optimize their product and corporate development strategies,
maximizing return on investment opportunities. Our solutions are based on targeted and timely evidence combined with industry, functional and
disease area expertise culminating in actionable implications and recommendations.
The practices are split by the following business function:
- Research & Development
- Clinical Development
- In-Line Marketing
- Business Development & Licensing
- Corporate Development
- Emerging Markets
- Generics and Biosimilars
and support the major therapeutic areas including: Oncology & Hematology; Immunology, Autoimmunity & Inflammation; Cardiology; Metabolic
Diseases; Neurology & Psychiatry; Infectious Diseases & Vaccines; Ophthalmology; Dermatology; Bone Disease; Gastroenterology & Urology;
and Women’s Health.
For further information please contact us on enquiries@prescientls.com
Profitable since its inception, the multi-awarded Digimind Company markets competitive intelligence solutions to face the challenge of digital
information explosion.
The web-based Digimind platform is the only integrated and one-stop shop solution that automates all repetitive intelligence activities from data
collection to information management, analysis and dissemination.
Digimind is essential for any corporation anxious to protect its assets and to secure its internal or external growth by raising their market awareness
and converting it in actionable decisions.
information explosion.
The web-based Digimind platform is the only integrated and one-stop shop solution that automates all repetitive intelligence activities from data
collection to information management, analysis and dissemination.
Digimind is essential for any corporation anxious to protect its assets and to secure its internal or external growth by raising their market awareness
and converting it in actionable decisions.
SAI is a global provider of high quality intelligence and strategy support services for the pharmaceutical and medical device industries. With over 30
years experience in competitive intelligence, an unparalleled global footprint and deep therapeutic area expertise, we remain a trusted partner
committed to driving critical insights for our clients.
years experience in competitive intelligence, an unparalleled global footprint and deep therapeutic area expertise, we remain a trusted partner
committed to driving critical insights for our clients.
EvaluatePharma offers a unique commercial perspective on the pharma and biotech business, in a user-friendly online subscription service. For
industry insiders and the investment sector, EvaluatePharma supports value-enhancing business decisions with proprietary insight into the
commercial and financial prospects of the pharma and biotech industry.
industry insiders and the investment sector, EvaluatePharma supports value-enhancing business decisions with proprietary insight into the
commercial and financial prospects of the pharma and biotech industry.
PharmaVoxx provides timely visual insight into competitor messaging tactics and promotional strategies. Our comprehensive, digitized library of
marketing and promotional literature and innovative track-and-analysis solutions delivers highly relevant, actionable information with precision and
ease. Watch your competition’s every marketing move, with PharmaVoxx. www.pharmavoxx.com
marketing and promotional literature and innovative track-and-analysis solutions delivers highly relevant, actionable information with precision and
ease. Watch your competition’s every marketing move, with PharmaVoxx. www.pharmavoxx.com
The Industry Leader in Global Visual Marketing Intelligence and Surveillance. Our premier product, CD PROMO Worldwide is the most comprehensive
online database of print promotion for the global pharmaceutical industry, providing full subscribers with access to over 1,000,000 scanned images. Turn
to the dtw professional staff for the most personalized service and customized solutions to meet your business goals. Multi-channel searchfunctionality
allows for “quick searches” while still retaining the advanced search features that allow for the best in depth of data and information. All facets of the
marketing mix are captured within our service, from physician to DTC, Managed Care to Pharmacy, NP and PA to Conventions and online E-
Communications. Syndicated and custom analysis projects and online research expertise complement the comprehensive CI database and is our core
competency and specialty. We are the Global Competitive Intelligence Experts.
online database of print promotion for the global pharmaceutical industry, providing full subscribers with access to over 1,000,000 scanned images. Turn
to the dtw professional staff for the most personalized service and customized solutions to meet your business goals. Multi-channel searchfunctionality
allows for “quick searches” while still retaining the advanced search features that allow for the best in depth of data and information. All facets of the
marketing mix are captured within our service, from physician to DTC, Managed Care to Pharmacy, NP and PA to Conventions and online E-
Communications. Syndicated and custom analysis projects and online research expertise complement the comprehensive CI database and is our core
competency and specialty. We are the Global Competitive Intelligence Experts.
Make quicker and more informed strategic decisions using industry leading databases from Adis. Easily monitor drug pipelines worldwide and
accurately assess potential of products in development with Adis R&D Insight™. Quickly identify, track, and evaluate clinical trial evidence from
conferences, journals, and internet registries with Adis Clinical Trials Insight®.
accurately assess potential of products in development with Adis R&D Insight™. Quickly identify, track, and evaluate clinical trial evidence from
conferences, journals, and internet registries with Adis Clinical Trials Insight®.
BioMedTracker is an independent research service that offers proprietary clinical assessments and patient-based revenue forecasts of developmental
drugs within a comprehensive and intuitive drug information database. Clients from the pharmaceutical, biotech, and investment industries rely on
BioMedTracker for its insight on the likelihood of approval, commercial potential, and future data and regulatory catalysts for drugs within the
competitive landscape of every important disease and indication. Over the last several years, BioMedTracker has become the leader in providing
objective information alongside subjective clinical assessments on pipeline drugs worldwide. Visit www.biomedtracker.com for more information.
drugs within a comprehensive and intuitive drug information database. Clients from the pharmaceutical, biotech, and investment industries rely on
BioMedTracker for its insight on the likelihood of approval, commercial potential, and future data and regulatory catalysts for drugs within the
competitive landscape of every important disease and indication. Over the last several years, BioMedTracker has become the leader in providing
objective information alongside subjective clinical assessments on pipeline drugs worldwide. Visit www.biomedtracker.com for more information.
| 19-20 FEBRUARY 2013 |